Is Britannia Life Sciences Inc. (BLAB.CN) a Buy, Sell, or Hold?
CNQ : BLAB.CN
Britannia Life Sciences Inc.
$0.065 CAD
-$0.01 (-7.14%)
- Volume
- 25.45K
- Average Volume
- 78.31K
- Market Capitalization
- $10.55M
- P/E Ratio
- 0.51
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.14
- Year Low
- $0.06
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.55
Industry, Sector & symbol
| Stock Exchange | CNQ |
| CEO | Peter James Shippen |
| Industry | Biotechnology |
| Sector | Healthcare |
| Current Symbol | BLAB.CN |
| CUSIP | 11042D108 |
| CIK | None |
| Web | https://britannia.life |
| Phone | 416-433-9259 |
| Currency | CAD |
| Employees | 28 |
| Country | CA |
Liquidity
| Debt-to-Equity Ratio | 0.01 |
| Payout Ratio | 0.00 |
| Current Ratio | 3.55 |
| Quick Ratio | 3.55 |
| Cash Ratio | 0.38 |
Sales & Book Value
| Annual Sales | $369.28K |
| Price / Sales | -2.43 |
| Cash Flow | -0.03 |
| Price / Cash Flow | -2.57 |
| Price / Book | 0.61 |
Price Target and Rating
| Average Stock Price Forecast | |
| High Stock Price Forecast | |
| Low Stock Price Forecast | |
| Forecast Upside/Downside | % |
| Consensus Rating | Buy |
| Rating Score(0-5) | 4 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | -$0.0288 |
| Trailing P/E Ratio | 0.51 |
| PEG Ratio | 0.00 |
| P/E Growth | 0.00 |
| Net Income | $7.39M |
| Net Margin | -472.89% |
| Pretax Margin | -196.22% |
| Return on Equity | 240.12% |
| Return on Assets | 92.87% |
Financials Score
| AltmanZ Score | 1.01 |
| Piotroski Score | 5.00 |
| Working Capital | 12.19M |
| Total Assets | 22.06M |
| Ebit | -4.81M |
| Market Cap | 11.36M |
| Total Liabilities | 4.83M |
Poll Results
About Britannia Life Sciences Inc. (CNQ:BLAB.CN) Stock
Britannia Life Sciences Inc., headquartered in Toronto, Canada, offers specialized services in rigorous product evaluation, comprehensive safety analysis, and adherence to regulatory standards. The company supports businesses within the cosmetics, nutraceutical, and consumer packaged goods (CPG) sectors, operating extensively throughout the United Kingdom and various international markets. ...
Britannia Life Sciences Provides Corporate Update
2026-05-21 09:08:00
Toronto, Ontario--(Newsfile Corp. - May 21, 2026) - Britannia Life Sciences Inc. (CSE: BLAB) ("Britannia" or the "Company") today provides
Frequently Asked Questions
-
What is the current Britannia Life Sciences Inc. (BLAB.CN) stock price?
-
Britannia Life Sciences Inc.(CNQ:BLAB.CN) stock price is $0.065 in the last trading session. During the trading session, BLAB.CN stock reached the peak price of $0.14 while $0.06 was the lowest point it dropped to. The percentage change in BLAB.CN stock occurred in the recent session was --7.14% while the dollar amount for the price change in BLAB.CN stock was -$0.01.
-
BLAB.CN's industry and sector of operation?
-
The CNQ listed BLAB.CN is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of BLAB.CN?
-
Micah Simmons | Vice President of Corporate Development
Boris Novansky | President
Peter James Shippen | Chief Executive Officer & Director
Sarah Zilik | Secretary & Chief Financial Officer
| -
How many employees does BLAB.CN have?
-
Number of BLAB.CN employees currently stands at 28. BLAB.CN operates from 120 Adelaide Street West, Toronto, ON M5H 1T1, CA.
-
Link for BLAB.CN official website?
-
Official Website of BLAB.CN is: https://britannia.life
-
How do I contact BLAB.CN?
-
BLAB.CN could be contacted at phone #416-433-9259 and can also be accessed through its website. BLAB.CN operates from 120 Adelaide Street West, Toronto, ON M5H 1T1, CA.
-
How many shares of BLAB.CN are traded daily?
-
The average number of BLAB.CN shares traded daily for last 3 months was 78.31K.
-
What is the market cap of BLAB.CN currently?
-
The market value of BLAB.CN currently stands at $10.55M with its latest stock price at $0.065